* Novocure Ltd NVCR.OQ reported a quarterly adjusted loss
of 54
cents per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 50
cents per share.
* Revenue fell 10.5% to $126.05 million from a year ago;
analysts
expected $124.26 million.
* Novocure Ltd's reported EPS for the quarter was a loss
of 54
cents.
* The mean earnings estimate of analysts had fallen by
about 40%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Novocure Ltd shares had fallen by 2.8% this quarter and
lost 45.0% so far this year.
* The company reported a quarterly loss of $57.42 million.
* Wall Street's median 12-month price target for Novocure
Ltd is
$73.50
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data July
27 at 03:46 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.50 -0.54 Missed
Mar. 31 2023 -0.32 -0.50 Missed
Dec. 31 2022 -0.30 -0.36 Missed
Sep. 30 2022 -0.26 -0.25 Beat